Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: a review of Sydenham chorea and beyond
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Antineuronal autoantibodies are associated with the involuntary movement disorder Sydenham chorea (SC) and paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) which are characterized by the acute onset of tics and/or obsessive compulsive disorder (OCD). In SC and PANDAS, autoantibodies signal human neuronal cells and activate calcium calmodulin‐dependent protein kinase II (Ca MKII). Animal models immunized with group A streptococcal antigens demonstrate autoantibodies against dopamine receptors and concomitantly altered behaviours. Human monoclonal antibodies (mA bs) derived from SC target and signal the dopamine D2L (long) receptor (D2R). Antibodies against D2R were elevated over normal levels in SC and acute‐onset PANDAS with small choreiform movements, but were not elevated over normal levels in PANDAS‐like chronic tics and OCD. The expression of human SC‐derived anti‐D2R autoantibody V gene in B cells and serum of transgenic mice demonstrated that the human autoantibody targets dopaminergic neurones in the basal ganglia and other types of neurones in the cortex. Here, we review current evidence supporting the hypothesis that antineuronal antibodies, specifically against dopamine receptors, follow streptococcal exposures and may target dopamine receptors and alter central dopamine pathways leading to movement and neuropsychiatric disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763 · cited 2×
“D2 receptors are generally more complex than D1 because they are expressed pre- and post-synaptically (Beaulieu & Gainetdinov 2011).”
BackgroundSüdhof, T. C. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131412 · Cited by 2,547 · cited 1×
“Internalization might be expected as previous studies have shown that Abs to neuronal receptors can be internalized (Hughes et al. 2010), and it is well established that dopamine receptors undergo recycling (Parton & Richards 2003, Sudhof 2004, Wolstencroft et al. 2007).”
Swedo, S. E., Leonard, H. L., Garvey, M., Mittleman, B., Allen, A. J., Perlmutter, S., Dow, S., Zamkoff, J., Dubbert, B. K., & Lougee, L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.2.264 · Cited by 1,534
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis
Hughes, E. G., Peng, X., Gleichman, A. J., Lai, M., Zhou, L., Tsou, R., Parsons, T. D., Lynch, D. R., Dalmau, J., & Balice-Gordon, R. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0167-10.2010 · Cited by 1,143
Perlmutter, S. J., Leitman, S. F., Garvey, M. A., Hamburger, S., Feldman, E., Leonard, H. L., & Swedo, S. E. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12297-3 · Cited by 556 · cited 6×
“1995), and anti-inflammatory treatments such as steroids, plasmaphoresis and intravenous immunoglobulin treatment are effective (Perlmutter et al. 1999).”
BackgroundInfluentialHigh prevalence of obsessive–compulsive symptoms in patients with Sydenham's chorea
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.2.246 · Cited by 421
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.1.110 · Cited by 371
Gerfen, C., Keefe, K., & Gauda, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-12-08167.1995 · Cited by 283 · cited 1×
“Published by John Wiley & Sons Ltd, doi: 10.1111/apha.12614 93 ventral tegmental area as well as on neurones in the striatum (Gerfen et al. 1995, Kawaguchi et al. 1995, Surmeier et al. 2011, Anzalone et al. 2012).”
BackgroundInfluentialBrimberg, L., Benhar, I., Mascaro-Blanco, A., Alvarez, K., Lotan, D., Winter, C., Klein, J., Moses, A. E., Somnier, F. E., Leckman, J. F., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.56 · Cited by 202
Self-citation
Cited by
Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism
Rose, S., Bennuri, S. C., Davis, J. E., Wynne, R., Slattery, J. C., Tippett, M., Delhey, L., Melnyk, S., Kahler, S. G., MacFabe, D. F., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0089-z · Cited by 226
Shimasaki, C., Frye, R. E., Trifiletti, R., Cooperstock, M., Kaplan, G., Melamed, I., Greenberg, R., Katz, A., Fier, E., Kem, D., et al. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577138 · Cited by 61
Barzman, D. H., Jackson, H., Singh, U., Griffey, M., Sorter, M., & Bernstein, J. A. (2018) · Case Reports in Psychiatry · doi:10.1155/2018/8189067 · Cited by 7
Metadata
- Authors
- Cunningham, M. W., & Cox, C. J.
- Venue
- Acta Physiologica
- Publisher
- Wiley
- Published
- 2015-11-05
- Volume
- 216
- Issue
- 1
- Pages
- 90-100
- ISSN
- 1748-1708 (ISSN-L)
- 1748-1716
- OpenAlex
- W2161140251
- Cited by
- 69
- References
- 11
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.